Patrick M. Schlievert

Patrick M. Schlievert's AcademicInfluence.com Rankings

Biology

#5184

World Rank

#7608

Historical Rank

Microbiology

#196

World Rank

#229

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Patrick M. Schlievert Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Patrick M. Schlievert's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Exotoxins of Staphylococcus aureus. (2000) (1657)
The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage (1983) (1336)
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A (1989) (783)
Toxic shock syndrome and bacterial superantigens: an update. (2001) (746)
Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. (1993) (638)
Glycerol monolaurate prevents mucosal SIV transmission (2009) (633)
Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. (1981) (602)
Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus (1988) (574)
Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. (1987) (547)
Genome sequence of a serotype M3 strain of group A Streptococcus: Phage-encoded toxins, the high-virulence phenotype, and clone emergence (2002) (509)
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. (1990) (507)
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. (1990) (485)
Regulation of exoprotein gene expression in Staphylococcus aureus by agr (2004) (412)
Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. (1991) (397)
Comparative Molecular Analysis of Community- or Hospital-Acquired Methicillin-Resistant Staphylococcus aureus (2003) (395)
Staphylococcal and Streptococcal Superantigen Exotoxins (2013) (391)
Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. (2003) (386)
Quorum sensing in Staphylococcus infections. (2003) (364)
Role of superantigens in human disease. (1993) (360)
Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production (1995) (333)
Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome (1993) (321)
Identification of a Novel Two-Component Regulatory System That Acts in Global Regulation of Virulence Factors ofStaphylococcus aureus (2001) (310)
Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s (1992) (307)
Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production (1989) (281)
Crystal structure of a T-cell receptor β-chain complexed with a superantigen (1996) (280)
Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. (1993) (249)
Biochemical and Biological Properties of Staphylococcal Enterotoxin K (2001) (224)
Purpura fulminans due to Staphylococcus aureus. (2005) (215)
Crystal structure of the superantigen staphylococcal enterotoxin type A. (1995) (201)
Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome (1991) (198)
Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C (1982) (197)
Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. (1983) (190)
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. (1997) (189)
STAPHYLOCOCCAL ENTEROTOXIN B AND TOXIC-SHOCK SYNDROME TOXIN-1 ARE SIGNIFICANTLY ASSOCIATED WITH NON-MENSTRUAL TSS (1986) (188)
A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. (1990) (188)
Three-Dimensional Structure of the Complex between a T Cell Receptor β Chain and the Superantigen Staphylococcal Enterotoxin B (1998) (182)
A Novel Core Genome-Encoded Superantigen Contributes to Lethality of Community-Associated MRSA Necrotizing Pneumonia (2011) (182)
Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. (2010) (181)
Characterization of Virulence Factor Regulation by SrrAB, a Two-Component System in Staphylococcus aureus (2004) (174)
Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms (2010) (169)
Pathogenicity and resistance islands of staphylococci. (2001) (167)
Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor (1990) (155)
Models matter: the search for an effective Staphylococcus aureus vaccine (2014) (155)
Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction (1994) (153)
The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1. (1986) (153)
Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production. (1984) (151)
Structure and Biological Activities of Beta Toxin from Staphylococcus aureus (2007) (148)
A Mutational Analysis of the Binding of Staphylococcal Enterotoxins B and C3 to the T Cell Receptor β Chain and Major Histocompatibility Complex Class II (1998) (148)
Application of Staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism. (2000) (142)
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. (2001) (141)
Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). (1993) (139)
Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis. (1998) (138)
Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands. (2002) (137)
Glycerol Monolaurate Antibacterial Activity in Broth and Biofilm Cultures (2012) (136)
Genome Diversification in Staphylococcus aureus: Molecular Evolution of a Highly Variable Chromosomal Region Encoding the Staphylococcal Exotoxin-Like Family of Proteins (2003) (133)
Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. (2002) (131)
A Superantigen Hypothesis for the Pathogenesis of Chronic Hyperplastic Sinusitis with Massive Nasal Polyposis (2003) (130)
Superantigens Are Critical for Staphylococcus aureus Infective Endocarditis, Sepsis, and Acute Kidney Injury (2013) (128)
Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. (2002) (126)
Staphylococcal Toxic Shock Syndrome 2000–2006: Epidemiology, Clinical Features, and Molecular Characteristics (2011) (126)
Superantigen binding to a T cell receptor beta chain of known three- dimensional structure (1995) (124)
Exotoxins of Staphylococcus aureus (2000) (123)
Structure of toxic shock syndrome toxin 1. (1993) (123)
Characterization of Staphylococcus aureus Enterotoxin L (2003) (121)
The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease. (1997) (119)
Outbreak of group A streptococcus septicemia in children. Clinical, epidemiologic, and microbiological correlates. (1991) (117)
Molecular Characterization of a NovelStaphylococcus aureus Serine Protease Operon (2001) (117)
Characterization of a novel staphylococcal enterotoxin-like superantigen, a member of the group V subfamily of pyrogenic toxins. (2002) (114)
Effect of glycerol monolaurate on bacterial growth and toxin production (1992) (114)
Pyrogenic Toxin Superantigen Site Specificity in Toxic Shock Syndrome and Food Poisoning in Animals (2000) (112)
Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen. (1999) (110)
Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins (1978) (110)
Repression of the Staphylococcus aureus Accessory Gene Regulator in Serum and In Vivo (2002) (110)
The Innate Immune System Is Activated by Stimulation of Vaginal Epithelial Cells with Staphylococcus aureus and Toxic Shock Syndrome Toxin 1 (2005) (109)
Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. (2008) (108)
The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design. (2014) (107)
Selective Depletion Of Vβ-Bearing T Cells In Patients With Severe Invasive Group A Streptococcal Infections And Streptococcal Toxic Shock Syndrome (1995) (107)
Distinct T-cell receptor V beta gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein (1992) (105)
In Vivo Induction of Virulence and Antibiotic Resistance Transfer in Enterococcus faecalis Mediated by the Sex Pheromone-Sensing System of pCF10 (2002) (104)
The staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions (2007) (103)
Purification and characterization of group A streptococcal pyrogenic exotoxin type C (1977) (101)
Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization. (2011) (101)
Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. (1996) (100)
The Staphylococcus aureus Global Regulator MgrA Modulates Clumping and Virulence by Controlling Surface Protein Expression (2016) (99)
Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes (1991) (99)
Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes. (1985) (99)
Gram‐positive bacterial superantigen outside‐in signaling causes toxic shock syndrome (2011) (99)
Toxic shock syndrome: A newly recognized complication of influenza and influenzalike illness (1987) (95)
Temperature regulates bacterial protein production: possible role in rosacea. (2004) (95)
Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. (2008) (94)
TOXIC SHOCK SYNDROME TOXIN (1984) (94)
Reemergence of Staphylococcal Toxic Shock Syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 Surveillance Period (2004) (93)
Multiple Functional Domains of Enterococcus faecalis Aggregation Substance Asc10 Contribute to Endocarditis Virulence (2008) (92)
Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. (2000) (91)
Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. (1982) (89)
Bacterial growth inhibition by amniotic fluid (1975) (88)
Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation. (2004) (88)
Superantigen can reactivate bacterial cell wall-induced arthritis. (1993) (88)
Invasive group A streptococcal infections in children with varicella in Southern California. (1996) (87)
Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin (1979) (85)
Nucleotide sequence of streptococcal pyrogenic exotoxin type C (1988) (85)
Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. (2001) (84)
Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor. (1988) (84)
Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review. (1996) (83)
Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists (2007) (82)
Alteration of immune function by staphylococcal pyrogenic exotoxin type C: possible role in toxic-shock syndrome. (1983) (82)
Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. (1998) (81)
Oxygen and Carbon Dioxide Regulation of Toxic Shock Syndrome Toxin 1 Production by Staphylococcus aureus MN8 (2000) (81)
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. (1996) (81)
Role of the T Cell Receptor α Chain in Stabilizing TCR-Superantigen-MHC Class II Complexes (1999) (80)
Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses. (2012) (79)
Characterization of Two Novel Pyrogenic Toxin Superantigens Made by an Acute Rheumatic Fever Clone of Streptococcus pyogenes Associated with Multiple Disease Outbreaks (2002) (77)
Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources (1983) (76)
Production of pyrogenic exotoxin by groups of streptococci: association with group A. (1979) (75)
Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin (1979) (75)
Heterogeneity of group A streptococcal pyrogenic exotoxin type B (1978) (74)
Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults. (1994) (74)
Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells. (2006) (74)
Toxoids of Streptococcal Pyrogenic Exotoxin A Are Protective in Rabbit Models of Streptococcal Toxic Shock Syndrome (2000) (73)
Staphylococcal superantigens cause lethal pulmonary disease in rabbits. (2010) (73)
A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. (1992) (73)
Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock (1978) (73)
Staphylococcus aureus associated with toxic shock syndrome: phage typing and toxin capability testing. (1982) (72)
Glycerol Monolaurate Does Not Alter Rhesus Macaque (Macaca mulatta) Vaginal Lactobacilli and Is Safe for Chronic Use (2008) (72)
Bacteriophage association of streptococcal pyrogenic exotoxin type C (1989) (71)
An amino‐terminal domain of Enterococcus faecalis aggregation substance is required for aggregation, bacterial internalization by epithelial cells and binding to lipoteichoic acid (2004) (71)
Vaccination against Staphylococcus aureus pneumonia. (2014) (70)
Association of exotoxin-producing group A streptococci and severe disease in children. (1991) (69)
The Staphylococcus aureus ArlRS Two-Component System Is a Novel Regulator of Agglutination and Pathogenesis (2013) (69)
Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness (1989) (68)
Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins (1991) (68)
Preparation of toxic shock syndrome toxin-1. (1988) (67)
The immunopathogenesis and management of Kawasaki syndrome. (1998) (66)
The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. (1999) (65)
Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis. (1999) (65)
Glycerol Monolaurate Inhibits Candida and Gardnerella vaginalis In Vitro and In Vivo but Not Lactobacillus (2009) (65)
Bacteriophage involvement in group A streptococcal pyrogenic exotoxin A production (1986) (64)
Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin. (1993) (64)
Comparative Analysis of Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Activity in Serum and Lethality in Mice and Rabbits Pretreated with the Staphylococcal Superantigen Toxic Shock Syndrome Toxin 1 (2001) (64)
Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness. (1988) (64)
Staphylococcus aureus β-toxin production is common in strains with the β-toxin gene inactivated by bacteriophage. (2014) (64)
Development of Streptococcal Pyrogenic Exotoxin C Vaccine Toxoids That Are Protective in the Rabbit Model of Toxic Shock Syndrome1 (2000) (63)
Modulation of immune cell proliferation by glycerol monolaurate (1996) (63)
Cytolysins Augment Superantigen Penetration of Stratified Mucosa1 (2009) (62)
Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis. (1996) (61)
Unique superantigen activity of staphylococcal exfoliative toxins. (1999) (60)
Evidence for the involvement of endotoxin in toxic shock syndrome. (1987) (60)
Alpha-Toxin Promotes Staphylococcus aureus Mucosal Biofilm Formation (2012) (60)
Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies (1988) (60)
Use of Recombinase-Based In Vivo Expression Technology To Characterize Enterococcus faecalis Gene Expression during Infection Identifies In Vivo-Expressed Antisense RNAs and Implicates the Protease Eep in Pathogenesis (2011) (59)
Invasive group B streptococcal disease in children beyond early infancy. (1995) (59)
Localization of biologically important regions on toxic shock syndrome toxin 1 (1996) (58)
Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus. (1992) (58)
Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin‐1 in peripheral blood mononuclear cells from patients with atopic dermatitis (1995) (58)
Staphylococcus aureus α-toxin modulates skin host response to viral infection. (2012) (58)
Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells. (1991) (57)
Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group. (1998) (57)
Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1. (1994) (56)
Functional Characterization of Streptococcal Pyrogenic Exotoxin J, a Novel Superantigen (2001) (55)
In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post menses. (2005) (55)
AhrC and Eep Are Biofilm Infection-Associated Virulence Factors in Enterococcus faecalis (2013) (55)
Aggregation and Binding Substances Enhance Pathogenicity in Rabbit Models of Enterococcus faecalis Endocarditis (1998) (54)
ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand (2008) (54)
Streptococcus pyogenes pharyngitis: characterization of strains by multilocus enzyme genotype, M and T protein serotype, and pyrogenic exotoxin gene probing (1992) (54)
Staphylococcal superantigens interact with multiple host receptors to cause serious diseases (2014) (53)
Functional Analysis of the TCR Binding Domain of Toxic Shock Syndrome Toxin-1 Predicts Further Diversity in MHC Class II/Superantigen/TCR Ternary Complexes 1 (2003) (53)
Rat liver protein linking chemical and immunological detoxification systems (1992) (53)
Role of T Cells and Gamma Interferon during Induction of Hypersensitivity to Lipopolysaccharide by Toxic Shock Syndrome Toxin 1 in Mice (2001) (52)
Ecto-5′-Nucleotidase: A Candidate Virulence Factor in Streptococcus sanguinis Experimental Endocarditis (2012) (52)
Nucleotide sequence of the staphylococcal enterotoxin C1 gene and relatedness to other pyrogenic toxins (1987) (52)
Conservation of the biologically active portions of staphylococcal enterotoxins C1 and C2 (1989) (51)
Suppression of immunoglobulin-secreting cells from human peripheral blood by toxic-shock-syndrome toxin-1. (1986) (51)
Characterization and Expression Analysis ofStaphylococcus aureus Pathogenicity Island 3 (2002) (51)
Molecular analysis of staphylococcal superantigens. (2007) (50)
Antibodies to a Surface-Exposed, N-terminal Domain of Aggregation Substance Are Not Protective in the Rabbit Model of Enterococcus faecalis Infective Endocarditis (2001) (50)
Streptococcal toxic shock syndrome due to noninvasive pharyngitis. (1992) (50)
Transmission of 'toxic strep' syndrome from an infected child to a firefighter during CPR. (1991) (50)
Formation of vegetations during infective endocarditis excludes binding of bacterial-specific host antibodies to Enterococcus faecalis. (2002) (49)
Glycerol Monolaurate Inhibits Virulence Factor Production in Bacillus anthracis (2005) (49)
Analysis of toxic shock syndrome isolates producing staphylococcal enterotoxins B and C1 with use of southern hybridization and immunologic assays. (1989) (49)
Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens. (2007) (48)
Transfer of group A streptococcal pyrogenic exotoxin production to nontoxigenic strains of lysogenic conversion (1980) (48)
α and β Chains of Hemoglobin Inhibit Production of Staphylococcus aureus Exotoxins (2007) (48)
The Spl Serine Proteases Modulate Staphylococcus aureus Protein Production and Virulence in a Rabbit Model of Pneumonia (2016) (47)
Structural Evidence for the Evolution of Pyrogenic Toxin Superantigens (2000) (47)
Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage. (2003) (47)
Immunochemical assays for toxic shock syndrome toxin-1. (1988) (46)
Molecular population genetic evidence of horizontal spread of two alleles of the pyrogenic exotoxin C gene (speC) among pathogenic clones of Streptococcus pyogenes (1992) (46)
Glycerol Monolaurate and Dodecylglycerol Effects on Staphylococcus aureus and Toxic Shock Syndrome Toxin-1 In Vitro and In Vivo (2009) (45)
Comparison of Staphylococcus aureus strains for ability to cause infective endocarditis and lethal sepsis in rabbits (2012) (45)
Cloning of the gene, speB, for streptococcal pyrogenic exotoxin type B in Escherichia coli (1988) (45)
Staphylococcus aureus Exotoxins Are Present In Vivo in Tampons (2010) (44)
Localization of biologic functions of toxic shock syndrome toxin-1 by use of monoclonal antibodies and cyanogen bromide-generated toxin fragments. (1986) (44)
Chronic Superantigen Exposure Induces Systemic Inflammation, Elevated Bloodstream Endotoxin, and Abnormal Glucose Tolerance in Rabbits: Possible Role in Diabetes (2015) (44)
Heat shock proteins and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2′,3′ cyclic nucleotide 3′ phosphodiesterase that is cross‐reactive with a heat shock protein alters the course of EAE (1996) (44)
Toxic Shock Syndrome Staphylococcus Aureus: Effect of Tampons on Toxic Shock Syndrome Toxin 1 Production (1984) (42)
Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry (2018) (42)
Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants (1997) (42)
Cell and receptor requirements for streptococcal pyrogenic exotoxin T-cell mitogenicity (1991) (41)
Alpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxins. (2007) (41)
The role of superantigens in human diseases (1995) (41)
Cloning, Characterization, andSequencing ofan Accessory Gene Regulator (agr) inStaphylococcus aureus (1988) (41)
Nonspecific T-lymphocyte mitogenesis by pyrogenic exotoxins from group A streptococci and Staphylococcus aureus (1979) (41)
Menaquinone Analogs Inhibit Growth of Bacterial Pathogens (2013) (41)
Permeability of the middle ear to staphylococcal pyrogenic exotoxin in otitis media. (1980) (41)
Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus. (2011) (41)
Cytolysins, superantigens, and pneumonia due to community-associated methicillin-resistant Staphylococcus aureus. (2009) (41)
Enterococcus faecalis Endocarditis Severity in Rabbits Is Reduced by IgG Fabs Interfering with Aggregation Substance (2010) (41)
Streptococcal toxic shock-like syndrome as a complication of varicella. (1991) (41)
Vaginal Staphylococcus aureus Superantigen Profile Shift from 1980 and 1981 to 2003, 2004, and 2005 (2007) (40)
Molecular epidemiology of staphylococcal scalded skin syndrome in premature infants. (1998) (40)
Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus. (1999) (40)
Pathogenic mechanisms of enterococcal endocarditis (2000) (40)
Studies of the staphylococcal causation of toxic shock syndrome. (1981) (39)
Evaluation of coagulase-negative staphylococci for ability to produce toxic shock syndrome toxin 1 (1987) (39)
Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle‐controlled trial (2009) (38)
Recurrent toxin-mediated perineal erythema. (1996) (38)
Molecular analysis of staphylococcal superantigens. (2014) (38)
Superantigens: Molecular Biology: Immunology, and Relevance to Human Disease (1997) (37)
Clinical and microbiological characteristics of severe group A streptococcus infections and streptococcal toxic shock syndrome. (1995) (37)
Role of the T cell receptor alpha chain in stabilizing TCR-superantigen-MHC class II complexes. (1999) (37)
Novel Tissue Level Effects of the Staphylococcus aureus Enterotoxin Gene Cluster Are Essential for Infective Endocarditis (2016) (37)
Expression of staphylococcal enterotoxin C1 in Escherichia coli (1987) (37)
Paneth-cell-disruption-induced necrotizing enterocolitis in mice requires live bacteria and occurs independently of TLR4 signaling (2017) (36)
Loxosceles arizonica bite associated with shock. (1997) (36)
Repression of Staphylococcus aureus SrrAB using inducible antisense srrA alters growth and virulence factor transcript levels. (2007) (36)
Nosocomial transmission of a strain of Staphylococcus aureus causing toxic shock syndrome. (1986) (35)
Novel toxic shock syndrome toxin-1 amino acids required for biological activity. (2008) (35)
Association of Toxic Shock Syndrome Toxin-Secreting and Exfoliative Toxin-Secreting Staphylococcus aureus with Kawasaki Syndrome Complicated by Coronary Artery Disease (1997) (35)
The SrrAB two-component system regulates Staphylococcus aureus pathogenicity through redox sensitive cysteines (2020) (35)
The Staphylococcus aureus superantigen SElX is a bifunctional toxin that inhibits neutrophil function (2017) (35)
Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1. (1986) (34)
Localization of an immunologically functional region of the streptococcal superantigen pepsin-extracted fragment of type 5 M protein. (1993) (34)
Structures of five mutants of toxic shock syndrome toxin-1 with reduced biological activity. (1998) (34)
Staphylococcal Superantigens Stimulate Immortalized Human Adipocytes to Produce Chemokines (2013) (34)
Structural, energetic, and functional analysis of a protein-protein interface at distinct stages of affinity maturation. (2003) (33)
[6] Preparation of toxic shock syndrome toxin-1 (1988) (33)
Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers. (2014) (33)
Glycerol Monolaurate Microbicide Protection against Repeat High-Dose SIV Vaginal Challenge (2015) (33)
Toxic shock syndrome toxin 1 is encoded by a variable genetic element. (1989) (33)
Staphylococcal pyrogenic exotoxin type C: further characterization. (1982) (33)
Inhibition of ribonucleic acid synthesis by group A streptococcal pyrogenic exotoxin (1980) (32)
Resolution of highly purified toxic-shock syndrome toxin 1 into two distinct proteins by isoelectric focusing. (1986) (32)
Characterization of a Staphylococcus aureus Surface Virulence Factor That Promotes Resistance to Oxidative Killing and Infectious Endocarditis (2010) (32)
Evaluation of the Enterococcus faecalis Biofilm-Associated Virulence Factors AhrC and Eep in Rat Foreign Body Osteomyelitis and In Vitro Biofilm-Associated Antimicrobial Resistance (2015) (31)
Superantigens in Kawasaki syndrome. (1995) (31)
Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1. (1990) (31)
Toxic shock syndrome caused by a strain of Staphylococcus aureus that produces enterotoxin C but not toxic shock syndrome toxin-1. (1989) (31)
The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization (2019) (30)
A possible association of recurrent streptococcal infections and acute onset of obsessive-compulsive disorder. (2004) (30)
Group A streptococcal phage T12 carries the structural gene for pyrogenic exotoxin type A (2004) (30)
Molecular genetics of pyrogenic exotoxin "superantigens" of group A streptococci and Staphylococcus aureus. (1991) (30)
Biological and immunological properties of the carboxyl terminus of staphylococcal enterotoxin C1 (1989) (29)
Transcriptome Analysis of Enterococcus faecalis during Mammalian Infection Shows Cells Undergo Adaptation and Exist in a Stringent Response State (2014) (29)
Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels due to glycerol monolaurate in tampons. (2009) (29)
Staphylococcal Enterocolitis: Forgotten but Not Gone? (2010) (28)
Mechanisms of Immunoglobulin Action: Observations on Kawasaki Syndrome and RSV Prophylaxis (1994) (28)
Staphylococcal β-Toxin Modulates Human Aortic Endothelial Cell and Platelet Function through Sphingomyelinase and Biofilm Ligase Activities (2017) (28)
A Disintegrin and Metalloproteinase 17 (ADAM17) and Epidermal Growth Factor Receptor (EGFR) Signaling Drive the Epithelial Response to Staphylococcus aureus Toxic Shock Syndrome Toxin-1 (TSST-1)* (2012) (28)
The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome (1995) (28)
Streptococcal pyrogenic exotoxin type A (scarlet fever toxin) is related to Staphylococcus aureus enterotoxin B (1986) (28)
Toxic shock syndrome in a horse with Staphylococcus aureus pneumonia. (2003) (27)
Structure of streptococcal pyrogenic exotoxin A reveals a novel metal cluster (2000) (27)
The staphylococcal and streptococcal pyrogenic toxin family. (1996) (27)
Glycerol Monolaurate Contributes to the Antimicrobial and Anti-inflammatory Activity of Human Milk (2019) (27)
Mechanisms of pathogenesis of staphylococcal and streptococcal superantigens. (1998) (27)
Purification and characterization of staphylococcal pyrogenic exotoxin type B. (1980) (27)
Genetic studies on Staphylococcal strains from patients with toxic shock syndrome. (1982) (27)
The two-component system Bacillus respiratory response A and B (BrrA-BrrB) is a virulence factor regulator in Bacillus anthracis. (2007) (26)
Refined structures of three crystal forms of toxic shock syndrome toxin‐1 and of a tetramutant with reduced activity (1997) (26)
Engineering a soluble high-affinity receptor domain that neutralizes staphylococcal enterotoxin C in rabbit models of disease. (2013) (26)
The Biochemical and Immunological Properties of Toxic-Shock Syndrome Toxin-1 (Tsst-1) and Association with TSS (1985) (25)
Non-Aqueous Glycerol Monolaurate Gel Exhibits Antibacterial and Anti-Biofilm Activity against Gram-Positive and Gram-Negative Pathogens (2015) (25)
Molecular structure of staphylococcus and streptococcus superantigens (1995) (25)
The Zinc-Dependent Major Histocompatibility Complex Class II Binding Site of Streptococcal Pyrogenic Exotoxin C Is Critical for Maximal Superantigen Function and Toxic Activity (2003) (25)
Effect of Antipyretics on group A Streptococcal Pyrogenic Exotoxin Fever Production and Ability to Enhance Lethal Endotoxin Shock (1978) (25)
Toxic Shock Syndrome After Laminaria Insertion (2001) (25)
Ribavirin mitigates wart growth in rabbits at early stages of infection with cottontail rabbit papillomavirus. (1992) (24)
Staphylococcal toxic shock syndrome erythroderma is associated with superantigenicity and hypersensitivity. (2009) (23)
Brucella sp. vertebral osteomyelitis with intercurrent fatal Staphylococcus aureus toxigenic enteritis in a bottlenose dolphin (Tursiops truncatus) (2011) (23)
Staphylococcal Exfoliative Toxins Cleave α- and β-Melanocyte-Stimulating Hormones (2000) (22)
Staphylococcus aureus Isolates from Patients with Kawasaki Disease Express High Levels of Protein A (1999) (22)
Activation of murine T-suppressor lymphocytes by group A streptococcal and staphylococcal pyurogenic exotoxins (1980) (22)
Group A Streptococcal Bacteremia in a Mid-South Children's Hospital (1993) (22)
Staphylococcus aureus β-Toxin Mutants Are Defective in Biofilm Ligase and Sphingomyelinase Activity, and Causation of Infective Endocarditis and Sepsis. (2016) (22)
Mutational Analysis of the Superantigen Staphylococcal Exfoliative Toxin A (ETA)1 (2000) (22)
Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin (1992) (21)
Biogenic Amine Involvement in Pyrogenicity and Enhancement of Lethal Endotoxin Shock by Group A Streptococcal Pyrogenic Exotoxin (1979) (21)
Extreme pyrexia and rapid death due to Staphylococcus aureus infection: analysis of 2 cases. (2009) (21)
Effect of magnesium on production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus. (1985) (21)
Neutralization of multiple staphylococcal superantigens by a single-chain protein consisting of affinity-matured, variable domain repeats. (2008) (21)
Staphylococcal α‐toxin causes increased tracheal epithelial permeability (2006) (21)
Temporal and Racial Differences Associated with Atopic Dermatitis Staphylococcus aureus and Encoded Virulence Factors (2016) (20)
Septic transfusion case caused by a platelet pool with visible clotting due to contamination with Staphylococcus aureus (2017) (20)
Streptococcal toxic shock syndrome, including necrotizing fasciitis and myositis (1994) (20)
Glycerol Monolaurate, an Analogue to a Factor Secreted by Lactobacillus, Is Virucidal against Enveloped Viruses, Including HIV-1 (2020) (20)
Toxins and Superantigens of Group A Streptococci. (2019) (19)
Staphylococcal and Streptococcal Superantigens: an Update (2007) (19)
Treatment of toxic shock syndrome with endotoxin-neutralizing antibody. (1989) (19)
Effect of magnesium on production of toxic-shock-syndrome toxin-1: a collaborative study. (1988) (19)
High Prevalence of Staphylococcus aureus Enterotoxin Gene Cluster Superantigens in Cystic Fibrosis Clinical Isolates (2019) (19)
Production of toxic shock syndrome-like illness in rabbits by Staphylococcus aureus D4508: association with enterotoxin A (1990) (19)
Analysis of the TCR Vβ Specificities of Bacterial Superantigens Using PCR (1993) (19)
Novel Antimicrobial Peptides That Inhibit Gram Positive Bacterial Exotoxin Synthesis (2014) (18)
Genetic Variation among Panton-Valentine Leukocidin-Encoding Bacteriophages in Staphylococcus aureus Clonal Complex 30 Strains (2013) (18)
Toxic shock-like syndrome associated with staphylococcal enterocolitis in an HIV-infected man. (2007) (18)
Mitogenic factors from group G streptococci associated with scarlet fever and streptococcal toxic shock syndrome. (1997) (18)
Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines (2019) (18)
Staphylococcus aureus Isolates Encode Variant Staphylococcal Enterotoxin B Proteins That Are Diverse in Superantigenicity and Lethality (2012) (17)
Sequence Analysis of the Staphylococcus aureus srrAB Loci Reveals that Truncation of srrA Affects Growth and Virulence Factor Expression (2007) (17)
Group A streptococcal peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. (1989) (16)
Augmentation of staphylococcal alpha-toxin signaling by the epidermal platelet-activating factor receptor. (2003) (16)
A Single, Engineered Protein Therapeutic Agent Neutralizes Exotoxins from Both Staphylococcus aureus and Streptococcus pyogenes (2010) (16)
Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin. (1995) (16)
Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. (1995) (16)
Glycerol Monolaurate (GML) and a Nonaqueous Five-Percent GML Gel Kill Bacillus and Clostridium Spores (2018) (15)
Epithelial Proinflammatory Response and Curcumin-Mediated Protection from Staphylococcal Toxic Shock Syndrome Toxin-1 (2012) (15)
Device-Associated Menstrual Toxic Shock Syndrome (2020) (15)
Cloning and characterization of the gene, speC, for pyrogenic exotoxin type C from Streptococcus pyogenes (1988) (15)
Group A streptococcal pyrogenic exotoxin (scarlet fever toxin) type A and blastogen A are the same protein (1989) (14)
Bacterial growth inhibition by amniotic fluid. III. Demonstration of the variability of bacterial growth inhibition by amniotic fluid with a new plate-count technique. (1975) (14)
The etiology and pathogenesis of Kawasaki disease – how close are we to an answer? (1997) (14)
Toxic shock-like syndrome, a complication of strep throat. (1991) (14)
Bacterial growth inhibition by amniotic fluid. IV. Studies on the nature of bacterial inhibition with the use of plate-count determinations. (1975) (14)
Vaginal Toxic Shock Reaction Triggering Desquamative Inflammatory Vaginitis (2013) (13)
Chitosan Malate Inhibits Growth and Exotoxin Production of Toxic Shock Syndrome-Inducing Staphylococcus aureus Strains and Group A Streptococci (2007) (13)
Case report: Molluscum contagiosum. Toxic shock syndrome following cantharidin treatment. (2003) (13)
Staphylococcus in toxic shock syndrome and other surgical infections. Development of new bacteriophages. (1983) (13)
Ganglioside and monosaccharide inhibition of nonspecific lymphocyte mitogenicity by group A streptococcal pyrogenic exotoxins (1980) (13)
Protection against staphylococcal pyrogenic exotoxin type C-enhanced endotoxin lethality with methylprednisolone and IgG. (1983) (13)
Biological properties of toxic shock syndrome exotoxin. (1984) (13)
Staphylococcal alpha-toxin causes increased tracheal epithelial permeability. (2006) (13)
Enterococcus faecalis Inhibits Superantigen Toxic Shock Syndrome Toxin-1-Induced Interleukin-8 from Human Vaginal Epithelial Cells through Tetramic Acids (2013) (12)
Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome. (2003) (12)
Toxinogenic vaginal infections due to Staphylococcus aureus in menstruating rhesus monkeys without toxic-shock syndrome. (1983) (12)
Staphylococcal scarlet fever: role of pyrogenic exotoxins (1981) (12)
Binding of toxic-shock-syndrome toxin-1 to human peripheral blood mononuclear cells. (1987) (12)
Reporting of toxic shock syndrome Staphylococcus aureus in 1982 to 1990. (1991) (11)
Biological and Immunological Properties of the Carboxyl Terminus of Staphylococcal Enterotoxin Cl (11)
Searching for superantigens. (1997) (11)
Novel Staphylococcus aureus Secreted Protein Alters Keratinocyte Proliferation and Elicits a Proinflammatory Response In Vitro and In Vivo. (2015) (11)
A physical map of the group A streptococcal pyrogenic exotoxin bacteriophage T12 genome (2004) (11)
Streptococcus agalactiae Toxic Shock-Like Syndrome (2013) (11)
Role of toxic shock syndrome toxin 1 in toxic shock syndrome: overview. (1989) (10)
Pyrogenic, lethal, and emetic properties of superantigens in rabbits and primates. (2003) (10)
Localization of a biologically important epitope on toxic-shock-syndrome toxin-1. (1988) (9)
Human Keratinocyte Response to Superantigens (2020) (9)
Staphylococcal and Streptococcal Superantigens (2003) (9)
Epidemiology of invasive streptococcal infections. (1998) (9)
Expression, purification, and detection of novel streptococcal superantigens. (2003) (9)
Does Staphylococcus aureus have a role in the development of Type 2 diabetes mellitus? (2015) (9)
Determining the Presence of Superantigens in Coagulase Negative Staphylococci from Humans (2015) (9)
An early favorable outcome of streptococcal toxic shock syndrome may require a combination of antimicrobial and intravenous gamma globulin therapy together with activated protein C (2006) (8)
Streptococcal Toxic Shock Syndrome (STSS) (1997) (8)
Streptococcal toxic shock in three Alabama children. (1993) (8)
Cloning and expression of streptococcal pyrogenic exotoxin A and staphylococcal toxic shock syndrome toxin-1 in Bacillus subtilis (1987) (8)
Natural phosphorylation of group A streptococcal pyrogenic exotoxin type C (1979) (8)
Successful management of a serious group A streptococcal infection during the third trimester of pregnancy. (1995) (8)
Staphylococcal Virulence Factors on the Skin of Atopic Dermatitis Patients (2019) (8)
Intravitreally injected human immunoglobulin attenuates the effects of Staphylococcus aureus culture supernatant in a rabbit model of toxin-mediated endophthalmitis. (2004) (8)
Will therapeutic peptides be kryptonite for superantigens? (2000) (8)
The spectrum of antibacterial activity of human amniotic fluid determined by scanning electron microscopy. (1974) (8)
Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1 (2019) (7)
Purification of Staphylococcus aureus beta-toxin: comparison of three isoelectric focusing methods. (1997) (7)
Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins. (1996) (7)
Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. Possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C. (1994) (7)
Kawasaki syndrome: role of superantigens revisited (2020) (6)
Biological activity of pyrogenic toxins delivered at the mucosal surface (1998) (6)
First reported case of streptococcus pyogenes infection with toxic shock-like syndrome in Italy (1992) (6)
Epidermal Growth Factor Receptor Signaling Enhances the Proinflammatory Effects of Staphylococcus aureus Gamma-Toxin on the Mucosa (2017) (6)
Local Epidermal Growth Factor Receptor Signaling Mediates the Systemic Pathogenic Effects of Staphylococcus aureus Toxic Shock Syndrome (2016) (5)
Staphylococcal Virulence Factors (2016) (5)
Pyrogenic Toxin Stimulation of TNF Production by Human Mononuclear Leukocytes and Effect of TNF on Neutrophil Chemotaxis (1990) (5)
Toxic Shock Syndrome (2001) (5)
Staphylococcal toxic shock syndrome: still a problem (2005) (5)
Detection of endotoxin by enhancement with toxic shock syndrome toxin-1 (TSST-1). (1988) (5)
Novel superantigens from streptococcal toxic shock syndrome Streptococcus pyogenes isolates. (1997) (5)
Growth and analysis of crystal forms of toxic shock syndrome toxin 1 (1993) (5)
Staphylococcal TSST-1 Association with Eczema Herpeticum in Humans (2021) (4)
Scalded skin syndrome (1998) (4)
The staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions (2007) (4)
Aortic Valve Damage for the Study of Left-Sided, Native Valve Infective Endocarditis in Rabbits. (2016) (4)
Purification of streptococcal pyrogenic exotoxin a. (2000) (4)
Endotoxin enhancement as a possible etiology of early-onset group B beta-hemolytic streptococcal sepsis in the newborn. (1983) (4)
Staphylococcal Enterotoxin C Subtypes Are Differentially Associated with Human Infections and Immunobiological Activities (2021) (3)
TOXIN-PRODUCING GROUP G STREPTOCOCCUS : A CASE REPORT AND REVIEW (1997) (3)
Identification, Purification, and Characterization of Staphylococcal Superantigens. (2016) (3)
A toroid model for in vitro investigations of toxic shock syndrome toxin-1 production. (2004) (3)
Structure of a superantigen T-cell receptor chain complex (1996) (3)
Toxic shock syndrome toxin-1, not α-toxin, mediated Bundaberg fatalities. (2015) (3)
Rabbit Model for Superantigen-Mediated Lethal Pulmonary Disease. (2016) (3)
Lack of efficient killing of purified dormant spores of Bacillales and Clostridiales species by glycerol monolaurate in a non‐aqueous gel (2020) (3)
Toxins and Superantigens of Group A Streptococci (2019) (2)
Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation. (1997) (2)
Bacterial Infection and Immunity (1986) (2)
The dream of Staphylococcal vaccination (2014) (2)
TSST-1+Staphylococcus aureus in Bullous pemphigoid. (2021) (2)
Reply to Landman and Groeneveld (2010) (2)
Are we close to a vaccination against Staphylococcus aureus? (2014) (2)
Stability of streptococcal pyrogenic exotoxin production with laboratory manipulation of group A streptococci. (1991) (2)
Pathogen Stimulation of Interleukin-8 from Human Vaginal Epithelial Cells through CD40 (2022) (2)
Five Percent Monolaurin Vaginal Gel for the Treatment of Bacterial Vaginosis: A Randomized Placebo-Controlled Trial (2020) (2)
Case report of an unusual presentation of Staphylococcus aureus induced toxic shock syndrome/hyperimmunoglobulinemia E syndrome (2020) (1)
Use of electroporation in genetic analysis of enterococcal virulence (1998) (1)
Antifungal Prophylaxis and the Rate of Bacteremia among Neutropenic Patients (2001) (1)
Enterococcus faecalis Infection-Associated Virulence Factors in AhrC and Eep Are Biofilm (2014) (1)
Decolonization of Human Anterior Nares of Staphylococcus aureus with Use of a Glycerol Monolaurate Nonaqueous Gel (2020) (1)
Clinical Infectious Disease: Staphylococcal and streptococcal toxic shock and Kawasaki syndromes (2008) (1)
Structural biology of toxins associated with toxic shock syndrome (1998) (1)
Cloning oftheGene,speB,forStreptococcal Pyrogenic Exotoxin TypeB inEscherichia coli (1988) (1)
Chapter 6. Exotoxins (2009) (1)
Reply to Dupieux et al. (2015) (1)
STRUCTURE OF STREPTOCOCCAL PYROGENIC EXOTOXIN A (2000) (1)
Complex of Streptococcal pyrogenic enterotoxin C (SpeC) with a human T cell receptor beta chain (Vbeta2.1) (2002) (0)
Prolonged Course of Toxic Shock Syndrome Associated with M & hicillin-Resistant Staphylekoccus aweus Enterotoxins (2004) (0)
Streptokoktoksin A-mutants, and methods of use (1996) (0)
Lipopolysaccharide-Induced Toxic Shock Syndrome in Rabbits. (2016) (0)
476 S. aureus virulence factors enhance vaccinia virus infection in human keratinocytes (2019) (0)
Abstract 11644: Infective Endocarditis Due to Staphylococcus Aureus and Lethality Are Critically Dependent on the Action of Superantigens (2014) (0)
Choice Toxic shock syndrome toxin-1 , not a-toxin , mediated Bundaberg fatalities (2015) (0)
Molecular Analysis ofPyrogenic Exotoxins from Streptococcus pyogenesIsolates Associated with ToxicShock-Like Syndrome (1991) (0)
Atomic resolution of crystal structure of SEK (2009) (0)
Staphylococcus Aureus Alpha-Toxin Augments Viral Load In Keratinocytes (2012) (0)
Staphylococcal superantigens interact with multiple host receptors to cause serious diseases (2014) (0)
Staphylococcus Aureus -Culture Positivity Observed In Adults With Atopic Dermatitis Is Most Indicative Of An Increased Absolute and Relative Abundance Of S. Aureus and Not Reduced Biodiversity (2018) (0)
GroupA Streptococcal Pyrogenic Exotoxin (Scarlet FeverToxin) TypeA andBlastogen A AretheSameProtein (1989) (0)
NIH Center for Scientific Review (CSR) (2013) (0)
Table of Contents (1995) (0)
Nonlesional Atopic Dermatitis Skin Shows Alterations in Langerhans Cells in Close Proximity to Tight Junction Fragmentation: 918 (2019) (0)
aureus Staphylococcus Methicillin-Resistant Community-or Hospital-Acquired Comparative Molecular Analysis of (2002) (0)
Erratum: Molecular structure of Staphylococcus and Streptococcus superantigens (Journal of Clinical Immunology (1995) Vol. 15 (p. 4S-10S)) (1996) (0)
094 TSST-1-producing Staphylococcus aureus in bullous pemphigoid (2019) (0)
Staphylococci: Abscesses and toxin-mediated diseases (2013) (0)
1362. A Novel Intravesical Antimicrobial for CAUTIs (2018) (0)
Menstrual TSS remains a dangerous threat (2020) (0)
Probable enterotoxin-associated toxic shock syndrome caused by Staphylococcus epidermidis (2023) (0)
Production of pyrogenic exotoxins in group a streptococci isolated from patients in Zagreb, Croatia (1992) (0)
Group a streptococcal peritonitis associated with continuous ambulatory peritoneal dialysis (1989) (0)
Nontoxigenic Strains by Lysogenic Conversion (0)
Streptococcal toxin mutant c methods of use. (1997) (0)
Mutational Analysis of the Superantigen (2000) (0)
666 Effect of dupilumab on the host-microbe interface in atopic dermatitis (2021) (0)
Kawasakiʼs disease: viral infection or toxic shock syndrome? (1995) (0)
Structural and biological analysis of genetic mutants of streptococcal pyrogenic exotoxin A (SPEA) (1998) (0)
Conservation oftheBiologically Active Portions ofStaphylococcal Enterotoxins ClandC2 (1989) (0)
Glycerol Monolaurate (GML) and a Nonaqueous Five-Percent GML Gel Kill <italic toggle='yes'>Bacillus</italic> and <italic toggle='yes'>Clostridium</italic> Spores (2019) (0)
Recurrent nonmenstrual toxic shock. (2002) (0)
carbon dioxide levels during and post menses In vivo assessment of human vaginal oxygen and (2015) (0)
Staphylococcus aureus Associated with Toxic Shock Syndrome (2020) (0)
Effect ofGlycerol Monolaurate on Bacterial Growth andToxinProduction (1992) (0)
018 TSST-1+ Staphylococcus aureus in bullous pemphigoid (2021) (0)
Host Cationic Antimicrobial Molecules Inhibit S. aureus Exotoxin Production (2023) (0)
Staphylococcus aureus pathogenicity island 3 ORF9 protein (2010) (0)
349 S. aureus superantigens enhance viral pathogenesis of the skin epithelium (2020) (0)
Protection against pyrogenic exotoxin type C enhanced endotoxin lethality with methylprednisolone and IgG (1983) (0)
Beta-hemolytic streptococcal erythroderma syndrome: a clinical and pathogenic analysis. (2011) (0)
Activities and structure of beta toxin (2008) (0)
Toxic shock syndrome and Kawasaki disease (2021) (0)
Genetics and virulence role of the classical group A Streptococcus Lancefield antigen (790.2) (2014) (0)
H135A MUTANT OF TOXIC SHOCK SYNDROME TOXIN-1 FROM S. AUREUS (1998) (0)
Tampons and toxic shock syndrome (1996) (0)
mitogenicity.pyrogenic exotoxin T-cell Cell and receptor requirements for (2013) (0)
ImmuneCellLethality Induced byStreptococcal Pyrogenic Exotoxin A andEndotoxin (1992) (0)
189 Microbial expression of lantibiotics may explain discrepancies between S. aureus culturability and metagenomics in atopic dermatitis subjects and healthy controls (2021) (0)
Exploring the pathophysiology of PANDAS: Streptococcus, Sydenham's and superantigens (2005) (0)
Novel SAG Purification and Detection 33 33 From : Methods in Molecular Biology (2002) (0)
Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1 (HA peptide 306-318) with the Superantigen SEC3 Variant 3B1 (2003) (0)
Staphylococcal Toxic Shock Syndrome, Superantigenicity, and Hypersensitivity. Authors' reply (2010) (0)
CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN B (1999) (0)
The biological role of the central helix toxic shock syndrome toxin-1 (1998) (0)
Staphylococcal Enterotoxin B and C Mutants and Vaccine Toxoids (2023) (0)
MY EXPERIENCES WITH TOXIC SHOCK SYNDROME RESEARCH (1998) (0)
Edinburgh Research Explorer Characterization of Staphylococcus aureus Enterotoxin L (2018) (0)
II / Superantigen / TCR Ternary Complexes Further Diversity in MHC Class of Toxic Shock Syndrome Toxin-1 Predicts Functional Analysis of the TCR Binding Domain (2003) (0)
The Ability of Human Immune Globulin to Attenuate the Toxic Effects of Pooled Staphylococcus aureus Exotoxins (2002) (0)
Streptococcus pyogenes Pharyngitis: Characterization of Strains by Multilocus Enzyme Genotype, M and T Protein Serotype, and Pyrogenic Exotoxin Gene Probing (1992) (0)
Reply: Toxin-Producing Staphylococcus aureus and Kawasaki Disease (1998) (0)
Severe Invasive Group A Streptococcal Disease with Rhabdomyolysis but without Evidence of Shock or Local Myositis (2009) (0)
Characterization of a Staphylococcus aureus Surface Virulence Factor That Promotes Resistance to Oxidative Killing and Infectious Endocarditis (cid:1) † (2010) (0)
EXFOLIATIVE TOXIN A (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Patrick M. Schlievert?

Patrick M. Schlievert is affiliated with the following schools:

University of Idaho
University of Texas Medical Branch
University of Oxford
University of Minnesota
Pennsylvania State University
Baylor College of Medicine
University of Iowa
University of North Carolina at Chapel Hill
University of Connecticut

Patrick M. Schlievert's Academic­Influence.com Rankings

Why Is Patrick M. Schlievert Influential?

Patrick M. Schlievert's Published Works

Published Works

What Schools Are Affiliated With Patrick M. Schlievert?

Patrick M. Schlievert's AcademicInfluence.com Rankings